Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy

This publication has 21 references indexed in Scilit:

• Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism
  Published by Springer Nature ,1989
• Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate
  Bone, 1988
• Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate
  Archives of internal medicine (1960), 1987
• Aminohexane diphosphonate in the treatment of paget' s disease of bone
  Journal of Bone and Mineral Research, 1987
• Effects of intravenous etidronate disodium on skeletal and calcium metabolism
  The American Journal of Medicine, 1987
• The Hypercalcemia of Cancer
  New England Journal of Medicine, 1984
• Comparison of two parenteral diphosphonates in hypercalcemia of malignancy
  The American Journal of Medicine, 1982
• Biochemical and clinical responses to dichloromethylene diphosphonate (cl₂mdp) in paget's disease of bone
  Arthritis & Rheumatism, 1980
• Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
  Journal of Clinical Investigation, 1980
• TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)
  The Lancet, 1979